Masahide Hiyoshi

Masahide Hiyoshi

Auto-generated profile, based on publicly available information

Masahide Hiyoshi

Division of Hepato-biliary-pancreas Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, Miyazaki, Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2007 in Journal of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Closed access
KCKazuo Chijiiwa
Kazuo Chijiiwa
MKMasahiro Kai
Masahiro Kai
MNMotoaki Nagano
Motoaki Nagano
MHMasahide Hiyoshi
Masahide Hiyoshi
JOJiro Ohuchida
Jiro Ohuchida
KKKazuhiro Kondo
Kazuhiro Kondo

12 May 2015 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MHMasahide Hiyoshi
Masahide Hiyoshi
YFYoshiro Fujii
Yoshiro Fujii
KKKazuhiro Kondo
Kazuhiro Kondo
NINaoya Imamura
Naoya Imamura
MNMotoaki Nagano
Motoaki Nagano
JOJiro Ohuchida
Jiro Ohuchida

1 November 2016 in International Journal of Surgery
Verified
Journal Article
Closed access
MHMasahide Hiyoshi
Masahide Hiyoshi
TWTakashi Wada
Takashi Wada
YTYuki Tsuchimochi
Yuki Tsuchimochi
THTakeomi Hamada
Takeomi Hamada
KYKoichi Yano
Koichi Yano
ANAtsushi Nanashima
Atsushi Nanashima
To reduce cholangitis after pancreaticoduodenectomy (PD), we perform 'hepaticoplasty', in which the left side of the bile duct is cut to widen the diameter of the bile duct wall before hepaticojejunostomy. The aim of this study was to clarify the usefulness of hepaticoplasty to reduce cholangitis after PD. From January 2002 through December 2010, 161 patients underwent PD and were enrolled in this study. Patient demographics, surgical factors, and clinical and biochemical parameters were evaluated to examine the factors predictive of cholangitis after PD and confirm the usefulness of hepaticoplasty. Cholangitis after PD occurred in 13 patients (8.1%). Multivariate analysis revealed that the ratio of the postoperative bile duct diameter to that before surgery was the only independent risk factor for cholangitis after PD (p = 0.0012). In the small bile duct group, in which the diameter was ≤15 mm before surgery (n = 99), hepaticoplasty reduced the narrowing of the bile duct after PD, and no cholangitis occurred. There were no complications related to hepaticoplasty. The ratio of postoperative reduction of the bile duct diameter to that before surgery was found to be the only risk factor for cholangitis after PD. Patients with a small bile duct of ≤15 mm in diameter preoperatively might benefit from hepaticoplasty to widen the bile duct diameter and prevent cholangitis after PD.

22 August 2007
Verified
Journal Article
Closed access
KKKazuhiro Kondo
Kazuhiro Kondo
KCKazuo Chijiiwa
Kazuo Chijiiwa
MNMotoaki Nagano
Motoaki Nagano
MHMasahide Hiyoshi
Masahide Hiyoshi
MKMasahiro Kai
Masahiro Kai
YOYoshiaki Ohkuwa
Yoshiaki Ohkuwa

11 October 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
ANAtsushi Nanashima
Atsushi Nanashima
MHMasahide Hiyoshi
Masahide Hiyoshi
NINO Imamura
NO Imamura
KYKoichi Yano
Koichi Yano
THTakeomi Hamada
Takeomi Hamada
KKKengo Kai
Kengo Kai
The therapeutic and diagnostic modalities of light are well known, and derivative photodynamic reactions with photosensitizers (PSs), specific wavelengths of light exposure and the existence of tissue oxygen have been developed since the 20th century. Photodynamic therapy (PDT) is an effective local treatment for cancer-specific laser ablation in malignancies of some organs, including the bile duct. Although curability for extrahepatic cholangiocarcinoma is expected with surgery alone, patients with unresectable or remnant biliary cancer need other effective palliative therapies, including PDT. The effectiveness of PDT for cholangiocarcinoma has been reported experimentally or clinically, but it is not the standard option now due to problems with accompanied photosensitivity, limited access routes of irradiation, tumor hypoxia, etc. Novel derivative treatments such as photoimmunotherapy have not been applied in the field hepatobiliary system. Photodynamic diagnosis (PDD) has been more widely applied in the clinical diagnoses of liver malignancies or liver vascularization. At present, 5-aminolevulinic acid (ALA) and indocyanine green (ICG) dyes are mainly used as PSs in PDD, and ICG has been applied for detecting liver malignancies or vascularization. However, no ideal tools for combining both PDD and PDT for solid tumors, including hepatobiliary malignancies, have been clinically developed. To proceed with experimental and clinical trials, it is necessary to clarify the effective photosensitive drugs that are feasible for photochemical diagnosis and local treatment.

28 January 2014 in International Journal of Oncology
Verified
Journal Article
Open access
NTNobuyasu Takahashi
Nobuyasu Takahashi
FAFumiyo Aoyama
Fumiyo Aoyama
MHMasahide Hiyoshi
Masahide Hiyoshi
HKHiroak Kataoka
Hiroak Kataoka
ASAkira Sawaguchi
Akira Sawaguchi
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications